https://www.selleckchem.com/pr....oducts/tucidinostat-
on in dose to multiple organs at risk vs the manual plan with a maximum value which ranged between 10.8 and 12.9 Gy for the three patients. The trade-off of the OAR dose reduction resulted in higher dose to no more than one OAR for each of the selected MCBOO plans vs the manual plan. The maximum dose increase in the MCBOO plans over the manual plan ranged from 7.8 to 11.8 Gy. CONCLUSIONS A novel multicriteria beam orientation optimization method was developed and tested on three IMPT patient cases. The method automaticall
Like
Comment
Share
